Derivatives of N- ``phenyl(piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics

Details for Australian Patent Application No. 2004281214 (hide)

Owner Sanofi-Aventis

Inventors Magat, Pascale; Estenne-Bouhtou, Genevieve; Dargazanli, Gihad

Agent Davies Collison Cave

Pub. Number AU-B-2004281214

PCT Pub. Number WO2005/037792

Priority 0312140 17.10.03 FR

Filing date 15 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 8 July 2010

International Classifications

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/037792 Priority application(s): WO2005/037792

8 July 2010 Application Accepted

  Published as AU-B-2004281214

4 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281215-Derivatives of N- [heteroaryl(piperidine-2-yl)methyl]benza mide, preparation method thereof and application of same in therapeutics

2004281195-Amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dih ydro-2H-chromen-6-yl derivatives, process and intermediate products for their preparation and medicaments containing these compounds